Overview

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to assess hormone withdrawal symptoms in women while taking an oral contraceptive in the novel 24/4 (24 days of "real" pills) manner in comparison to taking pills in the standard 21/7 (21 "real" pills) manner. It is hypothesized that the 24/4 method will reduce common hormone withdrawal symptoms compared to the standard 21/7 regimen. It is further hypothesized that women using the 24/4 regimen will report greater satisfaction scores.
Phase:
N/A
Details
Lead Sponsor:
Scott and White Hospital & Clinic
Collaborator:
Warner Chilcott
Treatments:
Mestranol
Norethindrone
Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
Norinyl